In humans, maternal CRMP1 autoantibodies have been associated with autism in their children, and increased CRMP1 mRNA levels were identified in individuals with schizophrenia, attention-deficit hyperactivity disorder, and ASD (Braunschweig et al., 2013; Bader et al., 2012). This evidence concerns the gene CRMP1 and autism.